Complement Activation in the Central Nervous System: A Biophysical Model for Immune Dysregulation in the Disease State

Complement Activation in the Central Nervous System: A Biophysical Model for Immune Dysregulation in the Disease State

DownLoad

Complement, a feature of the innate immune system that targets pathogens for phagocytic clearance and promotes inflammation, is tightly regulated to prevent damage to host tissue. This regulation is paramount in the central nervous system (CNS) since complement proteins degrade neuronal synapses during development, homeostasis, and neurodegeneration. We propose that dysregulated complement, particularly C1 or C3b, may errantly target synapses for immune-mediated clearance, therefore highlighting regulatory failure as a major potential mediator of neurological disease. First, we explore the mechanics of molecular neuroimmune relationships for the regulatory proteins: Complement Receptor 1, C1-Inhibitor, Factor H, and the CUB-sushi multiple domain family. We propose that biophysical and chemical principles offer clues for understanding mechanisms of dysregulation. Second, we describe anticipated effects to CNS disease processes (particularly Alzheimer's Disease) and nest our ideas within existing basic science, clinical, and epidemiological findings. Finally, we illustrate how the concepts presented within this manuscript provoke new ways of approaching age-old neurodegenerative processes. Every component of this model is testable by straightforward experimentation and highlights the untapped potential of complement dysregulation as a driver of CNS disease. This includes a putative role for complement-based neurotherapeutic agents and companion biomarkers.
Keywords: Alzheimer's disease; C1 inhibitor; CR1; complement; factor H; neuroimmune; schizophrenia.

Reference

1. Peoples, Nicholas, and Candace Strang. "Complement activation in the central nervous system: A biophysical model for immune dysregulation in the disease state." Frontiers in Molecular Neuroscience 14 (2021): 620090. under Open Access license CC BY 4.0, without modification

• Activation of the Complement System by Urban Particulate Matter
• Adipsin Is a Potential Predictor for Preeclampsia in Early Pregnancy
• Alternative C3 Complement System: Lipids and Atherosclerosis
• Antimicrobial Peptide as Complement System Modulator
• Autoantibodies Against the Complement Regulator Factor H in the Serum of Patients
• C4b Binding Protein Acts as an Innate Immune Effector Against Influenza A Virus
• Coagulation Complement Activation and Cerebral Hypoperfusion
• Complement Pathway Activation Is Associated With COVID-19 Mortality
• Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Subjects
• Complement DAF is a modulator of influenza A virus lung immunopathology
• Complement Regulation in Human Tenocytes under the Influence of Anaphylatoxin C5a
• Dendrimer end-terminal motif-dependent evasion of complement activation
• Inhibition of complement C5a receptor protects lung cells and tissues
• Interference of the Zika Virus E-Protein With the MAC of the Complement System
• Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins
• Microglial trogocytosis and the complement system regulate axonal pruning in vivo
• Modulation of complement activation by pentraxin-3 in prostate cancer
• Monitoring of the Complement System Status in Patients
• Monoclonal Antibodies Capable of Inhibiting Complement Downstream of C5
• REV-ERBα mediates complement expression and diurnal regulation of phagocytosis
• SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation
• Specific Evolution and Gene Family Expansion of C3 and Regulatory CFH in Fish
• Syk facilitates phagosome-lysosome fusion by regulating actin-remodeling
• The allosteric modulation of complement C5 by knob domain peptides
• The solution structure of the complement deregulator FHR5 reveals a compact dimer
• Two human antibodies enhance binding of CFH by stabilizing the CFH binding site